Metraipolis › archive › dc_b50ce67bef79

Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept — Europe PMC PMID:41869076

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41869076
DOI
10.1016/j.ijpx.2026.100514
License (as archived)
solo-consultazione
Archived
2026-11-04T23:30:20.595Z
SHA-256 of the archived text
0b142b99f362ae072c9b8280fc1469a0122cbc1c42c9fa5030c8ab74c6418ada
Stable URL of this page
https://metraipolis.com/documento/dc_b50ce67bef79

How to cite

Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept — Europe PMC PMID:41869076 — Europe PMC (en), https://europepmc.org/article/MED/41869076 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b50ce67bef79 (Metraipolis archive dc_b50ce67bef79, sha256 0b142b99f362ae072c9b8280fc1469a0122cbc1c42c9fa5030c8ab74c6418ada)
BibTeX
@misc{dcb50ce67bef79,
  title = {Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept — Europe PMC PMID:41869076},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41869076},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b50ce67bef79; sha256 0b142b99f362ae072c9b8280fc1469a0122cbc1c42c9fa5030c8ab74c6418ada},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869076. Agents can read the archived copy with the MCP tool read_document.